Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties

摘要

Described is the use of a farnesyl protein transferase inhibitor for the preparation of a pharmaceutical composition having radiosensitising properties for administration before during or after irradiation of a tumour for treating cancer, wherein the inhibitor is a compound of formula (I), (II) or (III).